Clinical Lymphoma, Myeloma and Leukemia
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.1 | Q1 | 76.7% | 0.615 | Q2 | 68.5% |
| 2024 | 2.7 | Q2 | 63.6% | 0.513 | Q3 | 63.0% |
| 2023 | 2.7 | Q3 | 46.0% | 0.548 | Q3 | 67.9% |
| 2022 | 2.7 | Q3 | 36.9% | 0.758 | Q2 | 79.0% |
| 2021 | 2.8 | Q4 | 39.5% | 0.778 | Q2 | 80.4% |
| 2020 | — | — | 0.940 | Q2 | 83.9% | |
| 2019 | — | — | 0.819 | Q2 | 80.9% | |
| 2018 | — | — | 1.059 | Q2 | 85.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2152-2669
ISSN
2152-2650
region
Northern America
coverage
2010-2026